INS and Insulin resistance: Despite these limitations, our study has several strengths, including the large sample size, side-by-side evaluation of multiple non–insulin-based IR surrogates, and the integration of bioinformatic pathway and mediation analyses, which together provide a coherent picture linking insulin resistance, glycemic pathways and prevalent CHD in this regional hospital-based studies.